{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:27:08Z","timestamp":1760171228775,"version":"3.37.3"},"reference-count":22,"publisher":"Portland Press Ltd.","issue":"10","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Vascular smooth muscle biology is increasingly exploited as an interventional target in vascular disease. Vascular smooth muscle Notch3\u2013Rho kinase\u2013cGMP interaction has been implicated in brain and peripheral arteriopathy in CADASIL. In the present commentary, we discuss the potential implications for other, more common non-atherosclerotic microvascular diseases: INOCA and HFpEF. The relation to mechanotransduction, to cellular senescence and to sGC activators as potential intervention agents are described.<\/jats:p>","DOI":"10.1042\/cs20210288","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T13:03:45Z","timestamp":1621515825000},"page":"1209-1212","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Notch\u2013Rho\u2013cGMP interaction: common point of convergence in microvascular aging-related disease"],"prefix":"10.1042","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-1756","authenticated-orcid":false,"given":"Anton\u00a0J.M.","family":"Roks","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Divisions of Vascular Disease and Pharmacology, Erasmus Medical Center, Erasmus University, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Cheng","sequence":"additional","affiliation":[{"name":"Experimental Cardiology, Department of Cardiology, Thorax center, Erasmus University Medical Center, Rotterdam, The Netherlands"},{"name":"Division of Internal Medicine and Dermatology, Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine\u00a0M.","family":"Shanahan","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre of Research Excellence, King\u2019s College London, School of Cardiovascular Medicine and Science, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"2021113011213426600_B1","article-title":"Cerebral autosomal dominant arteriopathy","author":"Cramer","year":"2020","journal-title":"StatPearls [Internet]"},{"key":"2021113011213426600_B2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1172\/JCI39733","article-title":"Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease","volume":"120","author":"Joutel","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2021113011213426600_B3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1042\/CS20201412","article-title":"Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO\/sGC\/cGMP pathway","volume":"135","author":"Neves","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011213426600_B4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/HYPERTENSIONAHA.120.15856","article-title":"Nitric Oxide-cGMP Signaling in Hypertension: Current and Future Options for Pharmacotherapy","volume":"76","author":"Ataei Ataabadi","year":"2020","journal-title":"Hypertension"},{"key":"2021113011213426600_B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/bcpt.13319","article-title":"The importance of the nitric oxide-cGMP pathway in age-related cardiovascular disease: Focus on phosphodiesterase-1 and soluble guanylate cyclase","volume":"127","author":"Golshiri","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"2021113011213426600_B6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/eurheartj\/ehx818","article-title":"Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg?","volume":"39","author":"Nelson","year":"2018","journal-title":"Eur. Heart J."},{"key":"2021113011213426600_B7","doi-asserted-by":"publisher","first-page":"e008868","DOI":"10.1161\/JAHA.118.008868","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): what is the risk?","volume":"7","author":"Herscovici","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"2021113011213426600_B8","doi-asserted-by":"publisher","first-page":"e002760","DOI":"10.1161\/CIRCHEARTFAILURE.115.002760","article-title":"Distinct endothelial cell responses in the heart and kidney microvasculature characterize the progression of heart failure with preserved ejection fraction in the obese ZSF1 rat with cardiorenal metabolic syndrome","volume":"9","author":"van Dijk","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"2021113011213426600_B9","doi-asserted-by":"publisher","first-page":"E3682","DOI":"10.1073\/pnas.1715277115","article-title":"Mechanosensitivity of Jagged-Notch signaling can induce a switch-type behavior in vascular homeostasis","volume":"115","author":"Loerakker","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011213426600_B10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/01.md.0000085054.63483.40","article-title":"Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)","volume":"82","author":"Lesnik Oberstein","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2021113011213426600_B11","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1093\/eurheartj\/ehy421","article-title":"Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction","volume":"39","author":"Santema","year":"2018","journal-title":"Eur. Heart J."},{"key":"2021113011213426600_B12","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2021113011213426600_B13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur. Heart J."},{"key":"2021113011213426600_B14","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1042\/CS20190835","article-title":"Notch3 signalling and vascular remodelling in pulmonary arterial hypertension","volume":"133","author":"Morris","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011213426600_B15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12012-015-9341-z","article-title":"Notch3 ameliorates cardiac fibrosis after myocardial infarction by inhibiting the TGF-beta1\/Smad3 pathway","volume":"16","author":"Zhang","year":"2016","journal-title":"Cardiovasc. Toxicol."},{"key":"2021113011213426600_B16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tcb.2018.03.001","article-title":"Crosstalk between YAP\/TAZ and Notch Signaling","volume":"28","author":"Totaro","year":"2018","journal-title":"Trends Cell Biol."},{"key":"2021113011213426600_B17","doi-asserted-by":"publisher","first-page":"e12936","DOI":"10.1111\/acel.12936","article-title":"Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson-Gilford progeria syndrome promotes arterial stiffness: therapeutic effect of dietary nitrite","volume":"18","author":"Del Campo","year":"2019","journal-title":"Aging Cell"},{"key":"2021113011213426600_B18","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.109.902056","article-title":"Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging","volume":"121","author":"Ragnauth","year":"2010","journal-title":"Circulation"},{"key":"2021113011213426600_B19","doi-asserted-by":"publisher","first-page":"e13152","DOI":"10.1111\/acel.13152","article-title":"Cytoskeleton stiffness regulates cellular senescence and innate immune response in Hutchinson-Gilford Progeria Syndrome","volume":"19","author":"Mu","year":"2020","journal-title":"Aging Cell"},{"key":"2021113011213426600_B20","doi-asserted-by":"publisher","first-page":"E748","DOI":"10.3390\/ijms17050748","article-title":"DNA damage: a main determinant of vascular aging","volume":"17","author":"Bautista-Nino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"2021113011213426600_B21","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040816","article-title":"Lamin mutations cause increased YAP nuclear entry in muscle stem cells","volume":"9","author":"Owens","year":"2020","journal-title":"Cells"},{"key":"2021113011213426600_B22","doi-asserted-by":"publisher","first-page":"e44948","DOI":"10.15252\/embr.201744948","article-title":"YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis","volume":"20","author":"He","year":"2019","journal-title":"EMBO Rep."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/10\/1209\/911997\/cs-2021-0288c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/10\/1209\/911997\/cs-2021-0288c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:18:13Z","timestamp":1638274693000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/135\/10\/1209\/228695\/Notch-Rho-cGMP-interaction-common-point-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,5,28]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20210288","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"type":"print","value":"0143-5221"},{"type":"electronic","value":"1470-8736"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2021,5]]}}}